title: Aerosolized surfactant improves pulmonary function in endotoxin-induced lung injury.
abstract: Surfactant dysfunction is a primary pathophysiologic component in patients with adult respiratory distress syndrome (ARDS). In this study we tested the efficacy of aerosolized surfactant (Sf ) replacement in a severe lung injury model of endotoxin-induced ARDS. Twenty-one certified healthy pigs were anesthetized, surgically prepared for measurement of hemodynamic and lung function, then randomized into one of four groups: (1) control (n = 5), surgical instrumentation only; (2) lipopolysaccharide (LPS) (n = 6), infused with Escherichia coli LPS (100 microgram/kg) without positive end- expiratory pressure (PEEP) and ventilated with a nonhumidified gas mixture of 50% N2O and 50% O2; (3) LPS + PEEP (n = 4), infused with LPS, placed on PEEP (7.5 cm H2O), and ventilated with a humidified gas mixture; and (4) LPS + PEEP + Sf (n = 6), infused with LPS, placed on PEEP, and ventilated with aerosolized Sf (Infasurf, ONY, Inc.). All animals were studied for 6 h. Arterial PO2 significantly decreased in both the LPS and LPS + PEEP groups (LPS + PEEP = 74 +/- 19 mm Hg; LPS = 74 +/- 19 mm Hg, p < 0.05) while venous admixture (Q S/Q T) increased in these groups (LPS + PEEP = 43.3 +/- 3.9%; LPS = 47.7 +/- 11%, p < 0.05) as compared with the control group. PEEP + Sf reduced the fall in PO2 (142 +/- 20 mm Hg) and rise in Q S/Q T (15.1 +/- 3.6%) caused by LPS. Delayed induction of PEEP (2 h following LPS) did not significantly improve any parameter over the LPS group without PEEP in this ARDS model. LPS without PEEP (3.4 +/- 0.2 cells/6,400 micrometer2) caused a marked increase in the total number of sequestered leukocytes in the pulmonary parenchyma as compared with the control group (1.3 +/- 0.1 cells/6,400 micrometer2). LPS + PEEP + Sf (2.3 +/- 0.2 cells/6,400 micrometer2) significantly decreased while LPS + PEEP significantly increased (4.0 +/- 0.2 cells/6,400 micrometer2) the total number of sequestered leukocytes as compared with the LPS without PEEP group. In summary, aerosolized surfactant replacement decreased leukocyte sequestration and improved oxygenation in our porcine model of endotoxin-induced lung injury.
authors.affiliation: SUNY Health Science Center at Syracuse, Department of Surgery, Syracuse, New York, USA.
authors.forename: C
authors.initials: C
authors.lastname: Lutz
authors.forename: D
authors.initials: D
authors.lastname: Carney
authors.forename: C
authors.initials: C
authors.lastname: Finck
authors.forename: A
authors.initials: A
authors.lastname: Picone
authors.forename: L A
authors.initials: LA
authors.lastname: Gatto
authors.forename: A
authors.initials: A
authors.lastname: Paskanik
authors.forename: E
authors.initials: E
authors.lastname: Langenback
authors.forename: G
authors.initials: G
authors.lastname: Nieman
mesh_terms: D000336:Aerosols; D018685:Anesthetics, Inhalation / Q000008:administration & dosage; D000818:Animals; D004195:Disease Models, Animal; D004731:Endotoxins / Q000009:adverse effects*; D004926:Escherichia coli; D007962:Leukocytes / Q000187:drug effects / Q000473:pathology; D008070:Lipopolysaccharides / Q000009:adverse effects; D008168:Lung / Q000187:drug effects* / Q000473:pathology / Q000503:physiopathology; D009330:Nebulizers and Vaporizers; D009609:Nitrous Oxide / Q000008:administration & dosage; D010100:Oxygen / Q000008:administration & dosage / Q000097:blood; D011175:Positive-Pressure Respiration; D011659:Pulmonary Gas Exchange / Q000187:drug effects; D011663:Pulmonary Surfactants / Q000008:administration & dosage / Q000627:therapeutic use*; D011897:Random Allocation; D012121:Respiration, Artificial; D012128:Respiratory Distress Syndrome / Q000188:drug therapy* / Q000473:pathology / Q000503:physiopathology; D013552:Swine; D014692:Ventilation-Perfusion Ratio / Q000187:drug effects
chemical_list: D000336:Aerosols; D018685:Anesthetics, Inhalation; D004731:Endotoxins; D008070:Lipopolysaccharides; D011663:Pulmonary Surfactants; D009609:Nitrous Oxide; D010100:Oxygen